Distribution and characterisation of lung mast cells in cystic fibrosis Source: Annual Congress 2009 - Airway inflammation and host defence Year: 2009
New insights into the pathophysiology of lung disease in cystic fibrosis patients Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-46-6, page=1 Year: 2006
Increased epithelial production of LPLUNC1 in cystic fibrosis lung disease Source: Annual Congress 2011 - Epithelial cell biology Year: 2011
Cystic fibrosis lung disease: from molecular defect to abnormal mucocilliary clearance Source: Annual Congress 2007 - PG4 - Paediatric respiratory medicine: cystic fibrosis – the basics Year: 2007
Targeting cystic fibrosis inflammation in the age of CFTR modulators: focus on macrophages Source: Eur Respir J, 57 (6) 2003502; 10.1183/13993003.03502-2020 Year: 2021
Correction of CFTR function in intestinal organoids to guide treatment of cystic fibrosis Source: Eur Respir J, 57 (1) 1902426; 10.1183/13993003.02426-2019 Year: 2021
The cystic fibrosis lung microenvironment alters antibiotic activity: causes and effects Source: Eur Respir Rev, 30 (161) 210055; 10.1183/16000617.0055-2021 Year: 2021
Investigation of the status of cystic fibrosis airway epithelial cells Source: Annual Congress 2008 - Multigenic expression analyses: a guide for diagnosis and therapy Year: 2008
What damages the cystic fibrosis lung epithelium: host or microbe? Source: Virtual Congress 2021 – Innate immunity and lung epithelial repair: what really happens? Year: 2021
Effects of flow-dependent and threshold PEP on lung functions in cystic fibrosis Source: Eur Respir J 2003; 22: Suppl. 45, 332s Year: 2003
Improving airway clearance in cystic fibrosis lung disease Source: Eur Respir Monogr 2014; 64: 169-187 Year: 2014
Is ceramide the missing link between the molecular defect and the lung disease of cystic fibrosis? Source: Breathe 2008; 4: 365 Year: 2008
Bacterial infection and lung function in patients with cystic fibrosis Source: Eur Respir J 2005; 26: Suppl. 49, 615s Year: 2005
Treatment of cystic fibrosis airway cells with CFTR modulators reverses aberrant mucus properties via hydration Source: Eur Respir J, 59 (2) 2100185; 10.1183/13993003.00185-2021 Year: 2022
The lung clearance index correlates with markers of pulmonary deterioration in patients with cystic fibrosis Source: Annual Congress 2013 –Cystic fibrosis: physiotherapy, exercise and lung function in adults and children Year: 2013
Comparison of progression in lung structure and lung function in children and adolescents with cystic fibrosis Source: Eur Respir J 2006; 28: Suppl. 50, 714s Year: 2006
Long-term clearance from small airways in patients with cystic fibrosis Source: Eur Respir J 2005; 25: 317-323 Year: 2005
Cystic fibrosis transmembrane conductance regulator pharmacotherapy Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-46-6, page=88 Year: 2006